Why REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease

Learn more about REXULTI for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

Pyrls on Instagram: Brexpiprazole's (REXULTI) new indication makes it the first FDA-approved option for agitation associated with dementia due to Alzheimer's disease ✨ Learn more about brexpiprazole in your Pyrls app or

Otsuka and Lundbeck Receive the US FDA's Approval for Rexulti (brexpiprazole) sNDA to Treat Agitation Associated with Dementia Due to Alzheimer's Disease

What is agitation that may happen with dementia due to Alzheimer's disease?

FAQ for agitation that may happen with dementia due to Alzheimer's disease

SLU Researcher Finds Help for Alzheimer's-Associated Agitation with New FDA-Approved Treatment : SLU

FDA Approves Rexulti For Agitation Associated With Dementia Due To Alzheimer's

First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum

FDA approves first drug to treat agitation symptoms associated with dementia due to Alzheimer's disease

Otsuka and Lundbeck Announce U.S. Food and Drug Administration (FDA) Approval of Supplemental New Drug Application (sNDA) for REXULTI® ( brexpiprazole) for the Treatment of Agitation Associated with Dementia Due to Alzheimer's Disease

FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients

This Month in Psychopharmacology

REXULTI® (Brexpiprazole) FDA Approved for Treating Agitation in Alzheimer's Disease Patients

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI® (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015